• Axsome Therapeutics EPS for the quarter ending September 30, 2024 was $-1.34, a 1.52% increase year-over-year.
• Axsome Therapeutics 2023 annual EPS was $-5.27, a 14.57% increase from 2022.
• Axsome Therapeutics 2022 annual EPS was $-4.6, a 32.56% increase from 2021.
• Axsome Therapeutics 2021 annual EPS was $-3.47, a 25.27% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.